Douglas Behr practices civil litigation and white collar criminal defense. He handles matters regulated by the Drug Enforcement Administration.
Mr. Behr represents businesses, trade associations, and individuals before federal and state trial and appellate courts, regulatory bodies, and licensing forums with a concentration on Lanham Act false advertising, contract disputes, white collar crime defense, product liability, and trade regulation controversies. He also advises members of the business community on litigation avoidance, and works with health care professionals and others on matters regulated by the Drug Enforcement Administration. Prior to entering private practice, Mr. Behr served 12 years as an Assistant United States Attorney, primarily as a prosecutor, and received a special achievement award from the Justice Department. He is a faculty member of the National Institute of Trial Advocacy. Mr. Behr is AV® PreeminentTM Rated by Martindale-Hubbell.
Mr. Behr is a contributing author of the Beyond Telecom Law Blog, Consumer Protection Connection blog, and Food Court Report.
Mr. Behr authored an article, Prescription Drug Control Under the Federal Controlled Substances Act: A Web of Administrative, Civil, and Criminal Law Controls, in the Washington University Law Urban Law Annual; Journal of Urban and Contemporary Law Volume 45, Issue 1 (1994).
Mr. Behr authored an article, Did you Forget to Say you're Sorry? Litigating a Show Cause Hearing for the Physician's DEA Registration, in the Quinnipiac University School of Law Health Law Journal, Volume 9, Number 1 (2005).
Mr. Behr authored an article, Challenging an Immediate Suspension of a DEA Registration: Is It Time for a New Tact?, in the Food and Drug Law Journal, Volume 69, Number 1 (2014).